Data from Pharmawand - Curated by EPG Health - Date added 12 January 2018

Spectra WaveWriter Spinal Cord Stimulator (SCS) System is FDA approved to treat chronic pain. SCS is the first and only system approved by the FDA to simultaneously provide paresthesia-based and sub-perception therapy. The system allows physicians and patients to combine therapeutic options, customize therapy and capture real-time feedback designed to treat chronic and debilitating pain successfully.

Spinal Cord Stimulation (SCS) System is an implanted spinal cord stimulation system that was previously indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs, including one-sided (unilateral) or two-sided (bilateral) pain associated with the following: failed back surgery syndrome, intractable low back and leg pain. The expanded indications include unilateral and bilateral pain associated with Complex Regional Pain Syndrome (CRPS) Type I and II. Additional associated conditions may be: radicular pain syndrome, radiculopathies resulting in pain secondary to failed back surgery syndrome or herniated disc, epidural fibrosis, degenerative disc disease, arachnoiditis, and multiple back surgeries.

The two main components include: 1. a stimulator device (signal generator) implanted under the skin that sends electrical signals to the spinal cord through an insulated lead wire, and 2. a hand-held remote control that allows the patient to control the implanted stimulator device in order to achieve the best pain control.

Comments

You will need to login, to leave a comment.

epgonline.org is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Migraine Knowledge Centre

Migraine Knowledge Centre

The Migraine Knowledge Centre features latest research on the prevalence and impact of migraine, the proposed neurological basis of the condition (and how this is being translated into new and exciting drug therapies), as well as current patient care strategies collated from headache organisations worldwide.

Pain, Agitation and Delirium (PAD) Management

Pain, Agitation and Delirium (PAD) Management

Discover the latest guidance on assessment and management of pain, agitation and delirium for patients requiring sedation.

+ 4 more

Fluid Management

Fluid Management

Are you up-to-date with the latest evidence of effective procedures for fluid management?

+ 2 more

Load more

Related Content